Pacific Biosciences of California, Inc. Gain (Loss) on Sale of Derivatives
Pacific Biosciences of California, Inc. (PACB) reported Gain (Loss) on Sale of Derivatives of $16.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2022-02-28
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for the quarter ending 2019-06-30 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for the quarter ending 2019-03-31 was $16.00K, a 90.64% decline year-over-year.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for fiscal 2019 was $16.00K, a 90.42% decline from fiscal 2018.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for fiscal 2018 was $167.00K.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for fiscal 2017 was -$653.00K, a 367.62% decline from fiscal 2016.
- Pacific Biosciences of California, Inc. gain (loss) on sale of derivatives for fiscal 2016 was $244.00K, a 29.07% decline from fiscal 2015.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $16.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $0.00 derived: sum of 2 quarters · filed 2020-11-03 | $16.00K 10-Q · filed 2020-11-03 | $28.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $16.00K 10-Q · filed 2020-08-06 | $28.00K derived: sum of 3 quarters · filed 2021-02-26 | $40.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $16.00K 10-Q · filed 2020-05-08 | $28.00K derived: sum of 2 quarters · filed 2021-02-26 | $40.00K derived: sum of 3 quarters · filed 2021-02-26 | $12.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $24.00K derived: sum of 2 quarters · filed 2021-02-26 | -$4.00K derived: sum of 3 quarters · filed 2021-02-26 | $167.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$16.00K derived: sum of 2 quarters · filed 2019-11-07 | $155.00K 10-Q · filed 2019-11-07 | $142.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $143.00K 10-Q · filed 2019-08-06 | $130.00K derived: sum of 3 quarters · filed 2020-02-28 | -$25.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $171.00K 10-Q · filed 2019-05-03 | $158.00K derived: sum of 2 quarters · filed 2020-02-28 | $3.00K derived: sum of 3 quarters · filed 2020-02-28 | -$630.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$168.00K derived: sum of 2 quarters · filed 2020-02-28 | -$801.00K derived: sum of 3 quarters · filed 2020-02-28 | -$653.00K 10-K · filed 2020-02-28 |
| 2017-09-30 | -$155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$788.00K derived: sum of 2 quarters · filed 2018-11-05 | -$640.00K 10-Q · filed 2018-11-05 | -$778.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$485.00K 10-Q · filed 2018-08-03 | -$623.00K derived: sum of 3 quarters · filed 2019-02-26 | -$577.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $148.00K 10-Q · filed 2018-05-02 | $10.00K derived: sum of 2 quarters · filed 2019-02-26 | $56.00K derived: sum of 3 quarters · filed 2019-02-26 | |
| 2016-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$92.00K derived: sum of 2 quarters · filed 2019-02-26 | $244.00K 10-K · filed 2019-02-26 | |
| 2016-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $382.00K 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $336.00K 10-Q · filed 2017-08-02 | |||
| 2015-12-31 | $344.00K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |